Patent ID: 7713981

Claim:
A method of inhibiting Omi/HtrA2 activity, from about 20% to about 90% comprising: contacting a cell having Omi/HtrA2 activity with an apoptosis inhibiting compound; and monitoring the inhibition of Omi/HtrA2 activity, wherein the apoptosis inhibiting compound is selected from the group consisting of: where R 1 is selected from the group consisting of a chloride, nitro group, a carboxy group, a hydroxide, an aliphatic group, an aromatic group, an acyl group, an alkoxy group, an alkylene group, an alkenylene group, an alkynylene group, a hydroxycarbonylalkyl group, an anhydride, an amide, an amine, and a heterocyclic aromatic group, and where R 2 is a methoxy group.